<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03806205</url>
  </required_header>
  <id_info>
    <org_study_id>PekingUPHmed</org_study_id>
    <nct_id>NCT03806205</nct_id>
  </id_info>
  <brief_title>Efficacy Management and Adherence Evaluation of Diclofenac in the Treatment of Knee Osteoarthritis Pain</brief_title>
  <official_title>Efficacy Management and Adherence Evaluation of Diclofenac in the Treatment of Knee Osteoarthritis Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University People's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Peking University People's Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the effect of dichloride on pain control of knee osteoarthritis and the&#xD;
      relationship between pain relief and medicine adherence. To evaluate the pain relief rate of&#xD;
      patients with different initial pain.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">January 15, 2019</start_date>
  <completion_date type="Anticipated">March 15, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 10, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>adherence</measure>
    <time_frame>6-8 weeks</time_frame>
    <description>We will calculate adherence with medication use</description>
  </primary_outcome>
  <primary_outcome>
    <measure>pain relief rate</measure>
    <time_frame>6-8 weeks</time_frame>
    <description>We will calculate the pain relief rate on all participants</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>womac score</measure>
    <time_frame>6-8 weeks</time_frame>
    <description>We will calculate the womac score on all participants</description>
  </secondary_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>To Investigate the Effect of Diclofenac on Pain Control of Knee Osteoarthritis and the Relationship Between Pain Relief and Medicine Adherence</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>regular follow-up</intervention_name>
    <description>we give a regular follow-up and supervision on the study group</description>
    <other_name>supervision</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  According to the OA diagnostic criteria of knee joint, the side with higher WOMAC&#xD;
             score is defined as observing knee joint for patients with both knees conforming to OA&#xD;
             diagnostic criteria.&#xD;
&#xD;
               1. Repeated knee pain in the past month&#xD;
&#xD;
               2. X-ray showed narrowing of articular space, subchondral sclerosis and/or cystic&#xD;
                  degeneration, and formation of osteophyte at articular margin.&#xD;
&#xD;
               3. Joint fluid (&gt; 2 times) is cool and sticky, WBC &lt; 2000/ml&#xD;
&#xD;
               4. Age over 40&#xD;
&#xD;
               5. Morning stiffness less than 30 minutes&#xD;
&#xD;
               6. Bone fricative (sensation) during exercise According to 1+2 or 1+3+5+6 or&#xD;
                  1+4+5+6, OA of knee joint can be diagnosed.&#xD;
&#xD;
               7. The informed consent has been signed&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  (1) Joint pain caused by other causes (infection, hip, lumbar and other diseases) (2)&#xD;
             Secondary arthritis (rheumatoid arthritis, ankylosing spondylitis, etc.) (3) Severe&#xD;
             internal medical complications and other inability to participate in the research (4)&#xD;
             Pain in other parts exceeds joint pain (5) Contraindications to diclofenac use: active&#xD;
             peptic ulcer/allergy/induced asthma (6) Assessment may not complete the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jianhao Lin, M.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Peking University People's Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Yudian Qiu, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>Peking University People's Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yudian Qiu, M.D.</last_name>
    <phone>+8613381150519</phone>
    <email>1210301417@pku.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jianhao Lin, M.D.</last_name>
    <email>linjianhao@pkuph.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peking University People's Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Xicheng District</state>
        <zip>100044</zip>
        <country>China</country>
      </address>
    </facility>
    <contact>
      <last_name>Yudian Qiu, M.D.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>da Costa BR, Reichenbach S, Keller N, Nartey L, Wandel S, JÃ¼ni P, Trelle S. RETRACTED: Effectiveness of non-steroidal anti-inflammatory drugs for the treatment of pain in knee and hip osteoarthritis: a network meta-analysis. Lancet. 2016 May 21;387(10033):2093-2105. doi: 10.1016/S0140-6736(16)30002-2. Epub 2016 Mar 18. Retraction in: Lancet. 2017 Jul 8;390(10090):109. Corrected and republished in: Lancet. 2017 Jul 8;390(10090):e21-e33.</citation>
    <PMID>26997557</PMID>
  </reference>
  <verification_date>January 2019</verification_date>
  <study_first_submitted>January 14, 2019</study_first_submitted>
  <study_first_submitted_qc>January 14, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">January 16, 2019</study_first_posted>
  <last_update_submitted>January 14, 2019</last_update_submitted>
  <last_update_submitted_qc>January 14, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">January 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Knee osteoarthritis pain; Adherence; Diclofenac; Follow up</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

